Q4 2024 |
120 |
$155M |
+$3.01M |
-$4.72M |
-$1.7M |
AAPL, MSFT, COST, ORCL, INTU
|
13F-HR |
2/11/2025, 06:48 PM |
Q3 2024 |
124 |
$158M |
+$5.24M |
-$5.83M |
-$589K |
MSFT, AAPL, COST, ORCL, INTU
|
13F-HR |
11/13/2024, 02:56 PM |
Q2 2024 |
119 |
$150M |
+$2.9M |
-$4.53M |
-$1.64M |
MSFT, AAPL, COST, INTU, ORCL
|
13F-HR |
8/12/2024, 05:33 PM |
Q1 2024 |
120 |
$149M |
+$5.23M |
-$4.48M |
+$749K |
MSFT, AAPL, INTU, COST, BRKB
|
13F-HR |
5/15/2024, 12:45 PM |
Q4 2023 |
117 |
$139M |
+$2.77M |
-$7.55M |
-$4.78M |
MSFT, AAPL, INTU, COST, GMED
|
13F-HR |
2/9/2024, 09:02 PM |
Q3 2023 |
120 |
$132M |
+$2.29M |
-$9.46M |
-$7.18M |
MSFT, AAPL, INTU, COST, BRKB
|
13F-HR |
11/13/2023, 06:48 PM |
Q2 2023 |
120 |
$144M |
+$2.18M |
-$4.26M |
-$2.08M |
MSFT, AAPL, GMED, INTU, ORCL
|
13F-HR |
8/14/2023, 01:52 PM |
Q1 2023 |
117 |
$141M |
+$3.26M |
-$1.42M |
+$1.84M |
MSFT, AAPL, INTU, GMED, COST
|
13F-HR |
5/12/2023, 12:22 PM |
Q4 2022 |
112 |
$136M |
+$1.64M |
-$9.4M |
-$7.75M |
MSFT, AAPL, GMED, INTU, BRKB
|
13F-HR |
2/13/2023, 05:21 PM |
Q3 2022 |
117 |
$135M |
+$11.3M |
-$1.95M |
+$9.3M |
MSFT, AAPL, GMED, INTU, COST
|
13F-HR |
11/14/2022, 03:22 PM |
Q2 2022 |
115 |
$139M |
+$578K |
-$2.79M |
-$2.21M |
MSFT, AAPL, GMED, COST, INTU
|
13F-HR |
8/10/2022, 02:24 PM |
Q1 2022 |
115 |
$163M |
+$2.1M |
-$3.36M |
-$1.25M |
MSFT, AAPL, GMED, INTU, COST
|
13F-HR |
5/12/2022, 01:59 PM |
Q4 2021 |
117 |
$175M |
+$1.72M |
-$2.29M |
-$575K |
MSFT, AAPL, INTU, GMED, COST
|
13F-HR |
2/11/2022, 07:44 PM |
Q3 2021 |
114 |
$160M |
+$3.72M |
-$1.29M |
+$2.43M |
MSFT, AAPL, INTU, GMED, BIV
|
13F-HR |
11/12/2021, 04:09 PM |
Q2 2021 |
116 |
$158M |
+$4.09M |
-$2.14M |
+$1.95M |
MSFT, AAPL, GMED, INTU, PYPL
|
13F-HR |
8/9/2021, 01:45 PM |
Q1 2021 |
113 |
$141M |
+$4M |
-$2.73M |
+$1.28M |
MSFT, AAPL, GMED, INTU, PYPL
|
13F-HR |
5/12/2021, 09:42 PM |
Q4 2020 |
111 |
$136M |
+$6.03M |
-$795K |
+$5.24M |
MSFT, AAPL, GMED, INTU, PYPL
|
13F-HR |
2/8/2021, 04:00 PM |
Q3 2020 |
105 |
$119M |
+$10.1M |
-$397K |
+$9.73M |
MSFT, AAPL, GMED, INTU, PYPL
|
13F-HR |
11/12/2020, 01:45 PM |
Q2 2020 |
99 |
$107M |
+$2.33M |
-$2.79M |
-$457K |
MSFT, AAPL, GMED, INTU, PYPL
|
13F-HR |
8/11/2020, 03:07 PM |
Q1 2020 |
96 |
$92M |
+$1.92M |
-$2.33M |
-$407K |
MSFT, AAPL, GMED, INTU, BRKB
|
13F-HR |
5/6/2020, 04:02 PM |
Q4 2019 |
112 |
$121M |
+$2.63M |
-$909K |
+$1.72M |
MSFT, GMED, AAPL, INTU, BRKB
|
13F-HR |
2/7/2020, 05:14 PM |
Q3 2019 |
109 |
$113M |
+$3.61M |
-$675K |
+$2.93M |
MSFT, GMED, AAPL, INTU, BRKB
|
13F-HR |
11/12/2019, 02:37 PM |
Q2 2019 |
107 |
$108M |
+$3.53M |
-$1.06M |
+$2.48M |
MSFT, GMED, INTU, AAPL, BRKB
|
13F-HR |
8/9/2019, 11:43 AM |
Q1 2019 |
104 |
$104M |
+$5.26M |
-$1.13M |
+$4.13M |
MSFT, GMED, INTU, AAPL, BRKB
|
13F-HR |
5/9/2019, 01:00 PM |
Q4 2018 |
100 |
$89.4M |
+$2.78M |
-$524K |
+$2.26M |
MSFT, GMED, BRKB, INTU, AAPL
|
13F-HR |
2/12/2019, 02:25 PM |
Q3 2018 |
110 |
$103M |
+$4.67M |
-$2.93M |
+$1.74M |
GMED, MSFT, AAPL, INTU, BRKB
|
13F-HR |
11/9/2018, 04:22 PM |
Q2 2018 |
109 |
$95.5M |
+$3.75M |
-$1.08M |
+$2.67M |
MSFT, GMED, AAPL, INTU, BRKB
|
13F-HR |
8/9/2018, 07:05 PM |
Q1 2018 |
107 |
$92.1M |
+$1.13M |
-$1.25M |
-$121K |
MSFT, GMED, BRKB, AAPL, INTU
|
13F-HR |
5/10/2018, 03:35 PM |
Q4 2017 |
122 |
$98.8M |
+$594K |
-$4.92M |
-$4.33M |
MSFT, GMED, BRKB, AAPL, PGXXXXX
|
13F-HR |
2/13/2018, 11:01 AM |
Q3 2017 |
129 |
$99.6M |
+$2.05M |
-$4.72M |
-$2.67M |
MSFT, AAPL, BRKB, PGXXXXX, GMED
|
13F-HR |
11/9/2017, 02:41 PM |
Q2 2017 |
127 |
$101M |
+$1.39M |
-$2.42M |
-$1.03M |
MSFT, AAPL, BRKB, GMED, PGXXXXX
|
13F-HR |
8/14/2017, 01:36 PM |
Q1 2017 |
132 |
$102M |
+$2.34M |
-$1.51M |
+$826K |
MSFT, AAPL, BRKB, PGXXXXX, GMED
|
13F-HR |
5/11/2017, 02:51 PM |
Q4 2016 |
131 |
$97.7M |
+$1.93M |
-$3.36M |
-$1.43M |
MSFT, BRKB, IWM, PGXXXXX, JNJ
|
13F-HR |
2/14/2017, 05:26 PM |
Q3 2016 |
134 |
$96.8M |
+$3.51M |
-$1.76M |
+$1.75M |
MSFT, PGXXXXX, JNJ, IWM, BRKB
|
13F-HR |
11/14/2016, 12:56 PM |
Q2 2016 |
128 |
$94.9M |
+$986K |
-$3.82M |
-$2.84M |
MSFT, PGXXXXX, JNJ, BRKB, GMED
|
13F-HR |
8/12/2016, 03:14 PM |
Q1 2016 |
134 |
$96.5M |
+$2.83M |
-$754K |
+$2.08M |
MSFT, PGXXXXX, BRKB, GMED, JNJ
|
13F-HR |
5/13/2016, 02:13 PM |
Q4 2015 |
137 |
$95.9M |
+$4M |
-$1.73M |
+$2.27M |
MSFT, GMED, PGXXXXX, BRKB, IWM
|
13F-HR |
2/16/2016, 12:57 PM |
Q3 2015 |
140 |
$91.3M |
+$3.83M |
-$1.22M |
+$2.6M |
PGXXXXX, MSFT, AAPL, BRKB, IWM
|
13F-HR |
11/12/2015, 09:57 AM |
Q2 2015 |
140 |
$98.4M |
+$8.04M |
-$3.94M |
+$4.1M |
PGXXXXX, MSFT, GMED, IWM, AAPL
|
13F-HR |
8/12/2015, 03:47 PM |
Q1 2015 |
135 |
$97.7M |
+$4.21M |
-$1.38M |
+$2.82M |
PGXXXXX, AAPL, GMED, BRKB, MSFT
|
13F-HR |
5/12/2015, 04:22 PM |
Q4 2014 |
283 |
$110M |
|
|
|
MSFT, PGXXXXX, BRKB, GMED, AAPL
|
13F-HR |
2/5/2015, 04:36 PM |